Studies related to Depression and Chromium

A Double-blind, Placebo-controlled, Exploratory Trial Of Chromium Picolinate In Atypical Depression: Effect On Carbohydrate Craving

Effect None
Trial Design Double blind
Trial Length 1-6 months
Number of Subjects 75
Sex Both Genders
Age Range 30-44, 45-64
Body Types Obese, Overweight
Notes for this study:
In adult outpatients with atypical depression given 600mcg chromium (as picolinate) daily over the course of eight weeks, supplementation failed to outperform placebo in the primary intention to treat (overall depressive symptoms as assessed by HAM-D) but when assessing the parameters associated with food intake and carbohydrate cravings chromium appeared to outperform placebo by reducing cravings and food consumption.

In persons with high baseline carbohydrate cravings, there was also an improvement in genital symptoms (ie. libido) relative to placebo.

Full details on all 5 studies are available to Examine Members. Try out the Examine Membership with a 14-day free trial.

Already a Member? Log in now to access.